Dr. Lal PathLabs Limited
LALPATHLAB
Rank in Stocks
#4510
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health... Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
Share Price
$20.35
Last synced: 2026-10-19
Market Cap
$3.40B
Change (1 day)
-0.86%
Change (1 year)
13.63%
Country
IN
Trade Dr. Lal PathLabs Limited (LALPATHLAB)
Category
Healthcare
Revenue for Dr. Lal PathLabs Limited (LALPATHLAB)
Revenue in Jun 2026 TTM: $319.03M
According to Dr. Lal PathLabs Limited latest financial reports the company's current revenue (TTM) is $319.03M. In 2024 the company made a revenue of $267.04M an increase over the revenue in the year 2023 that was $245.42M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Dr. Lal PathLabs Limited from 2011 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $319.03M | 10.85% |
| 2025 | $287.79M | 7.77% |
| 2024 | $267.04M | 8.81% |
| 2023 | $245.42M | -10.75% |
| 2022 | $274.99M | 27.30% |
| 2021 | $216.01M | 22.32% |
| 2020 | $176.59M | 1.90% |
| 2019 | $173.30M | 6.76% |
| 2018 | $162.33M | 15.38% |
| 2017 | $140.69M | 17.79% |
| 2016 | $119.44M | 13.00% |
| 2015 | $105.71M | -3.94% |
| 2014 | $110.04M | 32.38% |
| 2013 | $83.13M | 23.17% |
| 2012 | $67.49M | 26.76% |
| 2011 | $53.24M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $46.34B | 14,424.25% |
US
|
|
| $25.11B | 7,769.91% |
US
|
|
| $2.71B | 748.55% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 2,210.79% |
US
|
